Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12624000713594
Ethics application status
Approved
Date submitted
8/05/2024
Date registered
7/06/2024
Date last updated
13/10/2024
Date data sharing statement initially provided
7/06/2024
Type of registration
Prospectively registered
Titles & IDs
Public title
Evaluating a software-based model for improving management of the circulation of adult patients undergoing major surgery.
Query!
Scientific title
The pressure field: a feasibility trial of a Software-based Model for Optimisation of the Adult Circulation during Surgery (SMOACS).
Query!
Secondary ID [1]
312032
0
Nil known
Query!
Universal Trial Number (UTN)
U1111-1307-2908
Query!
Trial acronym
SMOACS
Query!
Linked study record
Not applicable
Query!
Health condition
Health condition(s) or problem(s) studied:
Management of perfusion during general anaesthesia
333639
0
Query!
Condition category
Condition code
Anaesthesiology
330324
330324
0
0
Query!
Anaesthetics
Query!
Cardiovascular
330325
330325
0
0
Query!
Normal development and function of the cardiovascular system
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The intervention group is the 'pressure field group'.
Anaesthetists in the pressure field group will receive clinical education on the pressure field method for managing perfusion. The pressure field method consists of defining a patient's baseline haemodynamic zone and defending this distinct haemodynamic zone during surgery.
The education consists of two 1-hour clinical education sessions, using the pressure field software to monitor three patients undergoing surgery, and completing an online questionnaire. The content includes the physiological basis for the haemodynamic zone, the process for determining a patient’s baseline haemodynamic zone, and strategies for maintaining parameters within the zone.
The zone is defined in terms of mean perfusion pressure (MPP), stroke volume (SV), and systemic elastance (Esys). The goal of intraoperative care is to maintain MPP within ±15% of the patient’s MPP baseline values without tolerating any MPP below 60 mmHg, and to maintain SV and Esys within ±15% of the patient’s baseline values. Anaesthetists will use the EV1000 or Hemosphere haemodynamic monitor, and the pressure field software, to support the management of patients.
No fluids, blood products, inotropes, or vasoactive drugs are to be administered prior to commencement of FloTrac monitoring. Roller clamps on fluid lines are to be closed except where fluid is actively being used to optimise the circulation. A vasopressor infusion is to be connected to the patient prior to induction (so that it can be promptly commenced as needed). Choice and titration of fluids, blood products, inotropes, and vasopressors is otherwise at the discretion of the attending anaesthetist.
Implementation scientists will measure the acceptability of the pressure field method by surveying participating anaesthetists at baseline, 6 months post-baseline, and 12 months post-baseline; assess the fidelity of intervention delivery by reviewing protocol deviations at 1, 6, and 12 months post-baseline (by auditing case report forms); and conduct semi-structured interviews with participating anaesthetists based on the Theoretical Domains Framework to identify and understand implementation barriers at 12 months post-baseline. If acceptability or intervention fidelity delivery is below 80%, enhancement strategies will be applied. Enhancement strategies may include additional clinical education or additional clinical research coordinator support in completing case report forms.
Anaesthetist participants will use the pressure field method until recruitment of the target number of patient participants in the pressure field group is complete.
Query!
Intervention code [1]
328478
0
Treatment: Devices
Query!
Intervention code [2]
328479
0
Treatment: Other
Query!
Comparator / control treatment
Anaesthetists in the control group will receive clinical education (a 1 hour lecture) on advanced haemodynamic monitoring and the evidence for avoiding hypotension.
The goal of intraoperative care is to maintain MPP within ±15% of the patient’s MPP baseline value without tolerating any MPP below 60 mmHg.
Anaesthetists will use the EV1000 or Hemosphere haemodynamic monitor to support the management of patients.
No fluids, blood products, inotropes, or vasoactive drugs are to be administered prior to commencement of FloTrac monitoring. Choice and titration of fluids, blood products, inotropes, and vasopressors is otherwise at the discretion of the attending anaesthetist.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
338077
0
Percentage of patients for whom complete haemodynamic data, key event data, and intervention data is available. This will be assessed as a composite outcome.
Query!
Assessment method [1]
338077
0
Complete haemodynamic data is defined as download and storage of a haemodynamic monitoring file; for the pressure field group, the file will be downloaded from the pressure field software, and for the control group, the file will be downloaded from the EV1000 or Hemosphere monitor. Complete event data is defined as a recorded start and end time of anaesthesia; start and end time of surgery; estimated blood loss and estimated start and end times for this; and estimated start and end time of any pneumoperitoneum or Trendelenburg or reverse Trendelenburg position. Complete intervention data is defined as recorded total fluid, blood product, inotrope, and vasoactive drug use. Event and intervention data is recorded in the case report form.
Query!
Timepoint [1]
338077
0
At the conclusion of study.
Query!
Secondary outcome [1]
434399
0
Percentage of patients with arterial line inserted prior to start of anaesthesia (induction)
Query!
Assessment method [1]
434399
0
Comparison of recorded times for insertion of arterial line and start of anaesthesia (induction). Times recorded in case report forms.
Query!
Timepoint [1]
434399
0
At the conclusion of study.
Query!
Secondary outcome [2]
434400
0
Percentage of patients with central line inserted prior to start of anaesthesia (induction).
Query!
Assessment method [2]
434400
0
Comparison of commencement time for recordal of central venous pressure values and recorded time for start of anaesthesia (induction). For central venous pressure, time in downloaded monitoring file inspected; for the pressure field group, the file will be downloaded from the pressure field software, and for the control group, the file will be downloaded from the EV1000 or Hemosphere monitor. For start of anaesthesia, times recorded in case report forms.
Query!
Timepoint [2]
434400
0
At the conclusion of study.
Query!
Secondary outcome [3]
434401
0
Percentage of patients with pre-operative and post-operative arterial blood gases (ABGs) taken.
Query!
Assessment method [3]
434401
0
Inspection of recorded ABG results. ABG results recorded in case report forms.
Query!
Timepoint [3]
434401
0
At the conclusion of study.
Query!
Secondary outcome [4]
434402
0
Recruitment rate (patients recruited per site per week).
Query!
Assessment method [4]
434402
0
Audit of recruitment records.
Query!
Timepoint [4]
434402
0
Measured after patient recruitment closes.
Query!
Secondary outcome [5]
434403
0
Percentage of patients in the pressure field group for which a ‘target haemodynamic zone’ was selected by the attending anaesthetist prior to start of anaesthesia (induction).
Query!
Assessment method [5]
434403
0
Inspection of recorded target haemodynamic zone in downloaded monitoring file and comparison to recorded start time of anaesthesia (induction). Monitoring file downloaded from pressure field software at the end of anaesthesia. Start times of anaesthesia recorded in case report forms.
Query!
Timepoint [5]
434403
0
At the conclusion of study.
Query!
Secondary outcome [6]
434404
0
Percentage of intraoperative case time patients spend with an MPP within ±15% of their pre-induction value.
Query!
Assessment method [6]
434404
0
Calculation based on recorded values in downloaded monitoring file. For the pressure field group, the file will be downloaded from the pressure field software, and for the control group, the file will be downloaded from the EV1000 or Hemosphere monitor.
Query!
Timepoint [6]
434404
0
Measured on the day of the primary operation for each patient.
Query!
Secondary outcome [7]
434405
0
Percentage of intraoperative case time that SV and Esys each remain within ±15% of the pre-induction values (as well as MPP within ±15% of the pre-induction value). This will be assessed as a composite outcome.
Query!
Assessment method [7]
434405
0
Calculation based on recorded values in downloaded monitoring file. This will be assessed as a composite outcome. For the pressure field group, the file will be downloaded from the pressure field software, and for the control group, the file will be downloaded from the EV1000 or Hemosphere monitor.
Query!
Timepoint [7]
434405
0
Measured on the day of the primary operation for each patient.
Query!
Secondary outcome [8]
434406
0
Percentage of intraoperative case time with MPP < 60mmHg.
Query!
Assessment method [8]
434406
0
Calculation based on recorded values in downloaded monitoring file. For the pressure field group, the file will be downloaded from the pressure field software, and for the control group, the file will be downloaded from the EV1000 or Hemosphere monitor.
Query!
Timepoint [8]
434406
0
Measured on the day of the primary operation for each patient.
Query!
Secondary outcome [9]
434407
0
Total fluid volumes (mL) administered during the intraoperative case time (including volume administered with drugs).
Query!
Assessment method [9]
434407
0
Inspection of recorded fluid volumes. Fluid volumes recorded in case report forms.
Query!
Timepoint [9]
434407
0
Measured on the day of the primary operation for each patient.
Query!
Secondary outcome [10]
434408
0
Change in haemoglobin (g/L) from pre-operation to post-operation (based on the pre-operative and post-operative ABGs).
Query!
Assessment method [10]
434408
0
Calculation based on inspection of recorded ABG results. ABG results recorded in case report forms.
Query!
Timepoint [10]
434408
0
Measured on the day of the primary operation for each patient.
Query!
Secondary outcome [11]
434409
0
Units of allogeneic red blood cells transfused during the intraoperative case time.
Query!
Assessment method [11]
434409
0
Inspection of recorded units. Units recorded in case report forms.
Query!
Timepoint [11]
434409
0
Measured on the day of the primary operation for each patient.
Query!
Secondary outcome [12]
434410
0
Total dose of vasopressors administered during the intraoperative case time expressed in ‘norepinephrine equivalents’.
Query!
Assessment method [12]
434410
0
Inspection of recorded doses. Doses recorded in case report forms.
Query!
Timepoint [12]
434410
0
Measured on the day of the primary operation for each patient.
Query!
Secondary outcome [13]
434411
0
Net recorded 48-hour fluid balance (for the day of surgery and day following surgery).
Query!
Assessment method [13]
434411
0
Inspection recorded values from Electronic Medical Record (EMR).
Query!
Timepoint [13]
434411
0
Collected on or about post-operative day 2 following the primary operation.
Query!
Secondary outcome [14]
434412
0
Acceptability of the pressure field as a method for managing perfusion.
Query!
Assessment method [14]
434412
0
Results of a theory-informed questionnaire (the Theoretical Framework of Acceptability questionnaire; Sekhon, Cartwright & Francis).
Query!
Timepoint [14]
434412
0
Measured at baseline, 6 months post-baseline, and 12 months post-baseline.
Query!
Secondary outcome [15]
434413
0
Fidelity of intervention delivery in the pressure field group.
Query!
Assessment method [15]
434413
0
Review of protocol deviations based on audit of case report forms.
Query!
Timepoint [15]
434413
0
Measured at 1 month post-baseline, 6 months post-baseline, and 12 months post-baseline.
Query!
Secondary outcome [16]
434414
0
Implementation barriers for the pressure field method of managing perfusion.
Query!
Assessment method [16]
434414
0
Result of semi-structured interviews based on the Theoretical Domains Framework.
Query!
Timepoint [16]
434414
0
Measured at 12 months post-baseline.
Query!
Eligibility
Key inclusion criteria
Anaesthetists: consultant anaesthetists who are regular users of advanced haemodynamic monitoring and who regularly provide anaesthetic care for major intra-abdominal surgery at a trial site.
Patients: scheduled for an elective intermediate- to high-risk abdominal surgical procedure and expected to be managed using a peripheral arterial catheter and central venous catheter connected to an EV1000 or Hemosphere monitor.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Anaesthetists: Anaesthetists who do not expect to be regularly providing care for major intra-abdominal surgery throughout the trial period.
Patients: Pregnancy or participation in a conflicting interventional clinical trial.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The randomisation will be generated by an independent statistician at the University of Melbourne (Australia).
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Anaesthetists will be randomly allocated to one of the two groups with 1:1 allocation via a computer-generated randomisation schedule.
Query!
Masking / blinding
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Anaesthetist and patient outcomes will be summarised.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
28/08/2024
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
1/06/2026
Query!
Actual
Query!
Date of last data collection
Anticipated
1/07/2026
Query!
Actual
Query!
Sample size
Target
100
Query!
Accrual to date
0
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Funding & Sponsors
Funding source category [1]
316383
0
Charities/Societies/Foundations
Query!
Name [1]
316383
0
Australia and New Zealand College of Anaesthetists Research Foundation
Query!
Address [1]
316383
0
Query!
Country [1]
316383
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Austin Health
Query!
Address
Query!
Country
Australia
Query!
Secondary sponsor category [1]
318565
0
None
Query!
Name [1]
318565
0
None
Query!
Address [1]
318565
0
Query!
Country [1]
318565
0
Query!
Other collaborator category [1]
283015
0
Hospital
Query!
Name [1]
283015
0
Peter MacCallum Cancer Centre
Query!
Address [1]
283015
0
Query!
Country [1]
283015
0
Australia
Query!
Other collaborator category [2]
283016
0
University
Query!
Name [2]
283016
0
University of Melbourne
Query!
Address [2]
283016
0
Query!
Country [2]
283016
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
315189
0
Austin Health Human Research Ethics Committee
Query!
Ethics committee address [1]
315189
0
https://www.austin.org.au/Office-for-Research/
Query!
Ethics committee country [1]
315189
0
Australia
Query!
Date submitted for ethics approval [1]
315189
0
15/04/2024
Query!
Approval date [1]
315189
0
24/07/2024
Query!
Ethics approval number [1]
315189
0
Query!
Summary
Brief summary
A critical part of an anaesthetist’s job is to make sure that the cells of a patient’s body continue to receive the right amount of oxygen. Oxygen delivery can't be directly measured, and anaesthetists rely on the surrogate measure of blood pressure. The pressure field software is real-time monitoring software which enables anaesthetists to understand how the heart and the body’s vessels are working together to generate blood pressure. This information, combined with a treatment algorithm, assists an anaesthetist in understanding what fluids or drugs will most help a patient. This may be particularly helpful for anaesthetists when they are caring for elderly patients, in whom it can be more challenging to know what fluids or drugs will work best. A large clinical trial evaluating the impact of the pressure field method on patient outcomes is being planned and this feasibility trial will 'road test' key elements of the planned large trial.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
133934
0
Dr Stephen Woodford
Query!
Address
133934
0
c/o Austin Hospital, 145 Studley Rd Heidelberg VIC 3084
Query!
Country
133934
0
Australia
Query!
Phone
133934
0
+61 467 979 118
Query!
Fax
133934
0
Query!
Email
133934
0
[email protected]
Query!
Contact person for public queries
Name
133935
0
Stephen Woodford
Query!
Address
133935
0
c/o Austin Hospital, 145 Studley Rd Heidelberg VIC 3084
Query!
Country
133935
0
Australia
Query!
Phone
133935
0
+61 467 979 118
Query!
Fax
133935
0
Query!
Email
133935
0
[email protected]
Query!
Contact person for scientific queries
Name
133936
0
Stephen Woodford
Query!
Address
133936
0
c/o Austin Hospital, 145 Studley Rd Heidelberg VIC 3084
Query!
Country
133936
0
Australia
Query!
Phone
133936
0
+61 467 979 118
Query!
Fax
133936
0
Query!
Email
133936
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
Query!
What data in particular will be shared?
Non-identifiable individual participant data underlying published results. No data that may be used to re-identify participants will be shared.
Query!
When will data be available (start and end dates)?
Beginning 3 months and ending 5 years following main results publication.
Query!
Available to whom?
On a case-by-case basis to academic authors. Requests from industry unaffiliated with an academic body such as a university will not be considered.
Query!
Available for what types of analyses?
Research which is an extension of or closely related to this study, for which there is a study protocol with ethics approval, and at the discretion of the Principal Investigator.
Query!
How or where can data be obtained?
By emailing the principal coordinating investigator at
[email protected]
.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF